Ignite Creation Date:
2024-05-06 @ 6:29 PM
Last Modification Date:
2024-10-26 @ 2:49 PM
Study NCT ID:
NCT05684939
Status:
COMPLETED
Last Update Posted:
2023-06-13
First Post:
2023-01-04
Brief Title:
Relation Between Substance Use and Pain in Patients Suffering or Surviving From Cancer and Followed in France
Sponsor:
University Hospital Clermont-Ferrand
Organization:
University Hospital Clermont-Ferrand
Study Overview
Official Title:
Study of the Relation Between the Consumption of Psychoactive Substances and Pain in Patients Suffering or Surviving From Cancer and Followed in France Cross-sectional Pilot Study
Status:
COMPLETED
Status Verified Date:
2022-12
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
CAPS
Brief Summary:
Pain is one of the most prevalent symptoms during and after cancer Pain can be the consequence of several situations disease progression surgery and anticancer drugs However pain can frequently be associated with a substance use disorder alcohol tobacco drugs and illicit products such as cannabis The relationship between substance use and pain is known to be complex and interdependent ie pain can reinforce substance use and substance use can promote pain However few data in the literature are available on the use of psychoactive substances in relation to pain in the context of cancer cancer patients and cancer survivors Moreover the scientific literature agrees on the fact that these elements are little studied and underestimated in the clinic
The investigators hypothesize that in cancer patients or cancer survivors the prevalence of the use of psychoactive substances would be higher in the presence of pain and would be associated with its intensity and its impact on the quality Health-Related Living HRQoL
The main objective of this study will be to compare in an adult population of patients suffering from cancer or having had cancer the prevalence of the consumption of psychoactive substances in painful patients compared to non-painful patients
The investigators hypothesize that in cancer patients or cancer survivors the prevalence of the use of psychoactive substances would be higher in the presence of pain and would be associated with its intensity and its impact on the quality Health-Related Living HRQoL
The main objective of this study will be to compare in an adult population of patients suffering from cancer or having had cancer the prevalence of the consumption of psychoactive substances in painful patients compared to non-painful patients
Detailed Description:
Patients will answer to an online questionnaire thanks to associations of cancer patients and social networks in order to explore their substance use and pain status
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None